Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis

INTRODUCTION: New oral anticoagulants (NOACs) are approved for use in nonvalvular atrial fibrillation (AF). OBJECTIVES: This study aimed to evaluate the efficacy and safety of NOACs compared with warfarin in AF and valvular heart disease (VHD). METHODS: We identified randomized controlled trials (RC...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza Lima Bitar, Yasmin, Neto, Mansueto Gomes, Filho, Jose Admirço Lima, Pereira, Larissa Vitória, Travassos, Kethyren Santos Oliveira, Akrami, Kevan M., Roever, Leonardo, Duraes, Andre Rodrigues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544604/
https://www.ncbi.nlm.nih.gov/pubmed/31055767
http://dx.doi.org/10.1007/s40268-019-0274-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544604/
https://www.ncbi.nlm.nih.gov/pubmed/31055767
http://dx.doi.org/10.1007/s40268-019-0274-z

Ejemplares similares